Annji Pharmaceutical Co., Ltd. (7754) Stock Price & Analysis
7754 Stock Chart & Stats
NT$60.30-NT$0.30(-0.50%)
At close: 1:32 AM EST
- Day’s Range
- TWD 57.00 - TWD 60.90
- 52-Week Range
- TWD 38.89 - TWD 86.00
- Previous Close
- TWD 60.60
- Volume
- N/A
- Average Volume (3M)
- 526.53K
- Market Cap
- TWD 6.10B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 460.26M
- Total Debt (Recent Filing)
- TWD 46.30M
- Price to Earnings (P/E)
- ―
- Beta
- 0.69
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
7754 FAQ
What was Annji Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Annji Pharmaceutical Co., Ltd. lowest stock price was TWD 38.89 and its highest was TWD 86.00 in the past 12 months.
What is Annji Pharmaceutical Co., Ltd.’s market cap?
Annji Pharmaceutical Co., Ltd.’s market cap is TWD 6.10B.
When is Annji Pharmaceutical Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Annji Pharmaceutical Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Annji Pharmaceutical Co., Ltd. pay dividends?
Annji Pharmaceutical Co., Ltd. does not currently pay dividends.
What is Annji Pharmaceutical Co., Ltd.’s EPS estimate?
Annji Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Annji Pharmaceutical Co., Ltd. have?
Annji Pharmaceutical Co., Ltd. has 101,130,540 shares outstanding.
Which hedge fund is a major shareholder of Annji Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in TW:7754
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Annji Pharmaceutical Co., Ltd.
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Wenying Huang
- Employees
- 80
- Website
- www.ajpharm.com
- Address
- 16F.-6, No. 508, Sec. 7, Taipei, TPE, 115011, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 3 | 12 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 2 | 0 | 10 |
